
As principal and founder of Cline Consulting and a senior executive of Biometrics, my expertise in legal expert, biostatistics, programming, data management, and decision science, coupled with my experience in data science, AI, drug development governance, and corporate integrations, allows me to develop and implement innovative statistical methods that overachieve targets and mitigate risk.
Expertise in the legal area as an expert witness, legal statistical evaluation and
deposition preparation.
I am known for my exceptional ability to communicate complex analytical methods and strategies effectively, making them vital to the enterprise's decision-making process and fostering team growth.
I aim to leverage methodology and analytics to innovate and transform the biopharmaceutical industry. I dedicate my time and energy to driving the frontiers of science and healthcare forward, and I hope to inspire others to join me in this transformative journey. I am currently serving as the Representative At-Large for the board of the Washington Statistical Society.
Bayesian designs, master protocols, and precision medicine to optimize clinical trials, reduce costs, and improve outcomes
Expert witness, legal statistical evaluation and deposition preparation
Clearly communicate statistical approaches in the language of drug development and market support as a drug developer
Analysis planning and execution, governance reviews, and regulatory submissions
Data Monitoring Committee expertise for creation and execution
Coaching for all levels of leaders with specific successful approaches for individual contributors to large group managers

2026
Leading statistical witness for $1.3 billion case.

2026
Leading Biometrics for 2 large development plans

2026
Conducting targeted short term consulting for multiple clients for drugs and devices